Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis

C. Moore, RZ. Blumhagen, IV. Yang, A. Walts, J. Powers, T. Walker, M. Bishop, P. Russell, B. Vestal, J. Cardwell, CR. Markin, SK. Mathai, MI. Schwarz, MP. Steele, J. Lee, KK. Brown, JE. Loyd, JD. Crapo, EK. Silverman, MH. Cho, JA. James, JM....

. 2019 ; 200 (2) : 199-208. [pub] 20190715

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006413

Grantová podpora
P01 HL092870 NHLBI NIH HHS - United States
U54 GM104938 NIGMS NIH HHS - United States
P30 AR053483 NIAMS NIH HHS - United States
MR/N005953/1 Medical Research Council - United Kingdom
P30 AR073750 NIAMS NIH HHS - United States
R01 HL097163 NHLBI NIH HHS - United States
UL1 RR024975 NCRR NIH HHS - United States
R33 HL120770 NHLBI NIH HHS - United States
U19 AI082714 NIAID NIH HHS - United States
K08 HL130595 NHLBI NIH HHS - United States

E-zdroje Online Plný text

NLK Free Medical Journals od 1997-07-01 do Před 1 rokem
Freely Accessible Science Journals od 1997 do Před 1 rokem
ProQuest Central od 2003-02-01 do 2019-09-15
Open Access Digital Library od 1998-01-01
Nursing & Allied Health Database (ProQuest) od 2003-02-01 do 2019-09-15
Health & Medicine (ProQuest) od 2003-02-01 do 2019-09-15
Public Health Database (ProQuest) od 2003-02-01 do 2019-09-15

Rationale: Several common and rare genetic variants have been associated with idiopathic pulmonary fibrosis, a progressive fibrotic condition that is localized to the lung. Objectives: To develop an integrated understanding of the rare and common variants located in multiple loci that have been reported to contribute to the risk of disease. Methods: We performed deep targeted resequencing (3.69 Mb of DNA) in cases (n = 3,624) and control subjects (n = 4,442) across genes and regions previously associated with disease. We tested for associations between disease and 1) individual common variants via logistic regression and 2) groups of rare variants via sequence kernel association tests. Measurements and Main Results: Statistically significant common variant association signals occurred in all 10 of the regions chosen based on genome-wide association studies. The strongest risk variant is the MUC5B promoter variant rs35705950, with an odds ratio of 5.45 (95% confidence interval, 4.91-6.06) for one copy of the risk allele and 18.68 (95% confidence interval, 13.34-26.17) for two copies of the risk allele (P = 9.60 × 10-295). In addition to identifying for the first time that rare variation in FAM13A is associated with disease, we confirmed the role of rare variation in the TERT and RTEL1 gene regions in the risk of IPF, and found that the FAM13A and TERT regions have independent common and rare variant signals. Conclusions: A limited number of common and rare variants contribute to the risk of idiopathic pulmonary fibrosis in each of the resequencing regions, and these genetic variants focus on biological mechanisms of host defense and cell senescence.

Advanced Lung Disease and Transplant Program Inova Fairfax Hospital Falls Church Virginia

Alfred Hospital and Monash University Melbourne Australia

Asan Medical Center University of Ulsan College of Medicine Seoul Korea

Biomedical Genomics Center University of Minnesota

Biomedical Research Centre University of Nottingham Nottingham United Kingdom

Brigham and Women's Hospital Harvard School of Medicine Boston Massachusetts

CardioPulmonary Reserach Center Alliance Pulmonary Group Guaynabo Puerto Rico

Cork University Hospital and University College Cork Cork Ireland

Department of Diseases of the Thorax Ospedale GB Morgagni Forlì Italy

Department of Internal Medicine University of Genoa Genoa Italy

Department of Medicine and

Department of Medicine and 20 Helmholtz Zentrum München Neuherberg Germany

Department of Medicine and 41 Tokyo Medical and Dental University Tokyo Japan

Department of Medicine Columbia University Irving Medical Center New York New York

Department of Medicine Tallaght University Hospital Trinity College Dublin Dublin Ireland

Department of Medicine University of Alabama at Birmingham Birmingham Alabama

Department of Medicine University of California San Francisco San Francisco California

Department of Medicine University of Chicago Chicago Illinois

Department of Medicine University of Virginia Charlottesville Virginia

Department of Medicine Vanderbilt University School of Medicine Nashville Tennessee

Department of Medicine Warren Alpert Medical School of Brown University Providence Rhode Island

Department of Pulmonary Medicine Gazi University School of Medicine Ankara Turkey

Department of Pulmonology Ege University Hospital Bornova Izmir Turkey

Department of Respiratory Diseases and Allergy Aarhus University Hospital Aarhus Denmark

Department of Respiratory Medicine 1st Faculty of Medicine Charles University and Thomayer Hospital Prague Czech Republic

Division of Pulmonary and Critical Care Medicine Massachusetts General Hospital Boston Massachusetts

Gilead Sciences Foster City California

Helmholtz Zentrum München Neuherberg Germany

Institute for Respiratory Health and

Institute for Respiratory Health and 43 Centre for Cell Therapy and Regenerative Medicine School of Biomedical Sciences The University of Western Australia Perth Australia

Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas México City México

Minneapolis Minnesota

MRC Centre for Inflammation Research University of Edinburgh Edinburgh United Kingdom

MRC Centre for Inflammation Research University of Edinburgh Edinburgh United Kingdom 9 Respiratory Medicine Unit Royal Infirmary of Edinburgh Edinburgh United Kingdom

National Hospital Organization Kinki Chuo Chest Medical Center Osaka Japan

National Hospital Organization Tokyo National Hospital Tokyo Japan

National Jewish Health Denver Colorado

National Jewish Health Denver Colorado 2 School of Public Health

National Jewish Health Denver Colorado 2 School of Public Health 3 Department of Medicine and

National Jewish Health Denver Colorado 3 Department of Medicine and

National Jewish Health Denver Colorado 3 Department of Medicine and 54 Department of Immunology University of Colorado Denver Denver Colorado

National University Hospital of Iceland University of Iceland Reykjavik Iceland

Northwest Genomics Center University of Washington Seattle Washington

Oklahoma Medical Research Foundation Oklahoma City Oklahoma

Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania

Pulmonary Medicine GB Morgagni Hospital Forlì Italy

Respiratory Department University Hospital of Bellvitge University of Barcelona Barcelona Spain

Respiratory Medicine Unit Royal Infirmary of Edinburgh Edinburgh United Kingdom

Royal Brompton Hospital and Imperial College London United Kingdom

Royal Papworth Hospital and Cambridge University Hospitals NHS Foundation Trust Cambridge United Kingdom

Royal Prince Alfred Hospital and University of Sydney Sydney Australia

Ruhrlandklinik University Hospital University of Duisburg Essen Essen Germany

Simmons Center for Interstitial Lung Disease University of Pittsburgh Pittsburgh Pennsylvania

St Vincent's University Hospital Dublin Ireland 38 School of Medicine University College Dublin Dublin Ireland

Tokyo Medical and Dental University Tokyo Japan

Universidad Nacional Autónoma de México México City México

Université Paris Diderot and Hôpital Bichat Paris France

University Hospital Munich Munich Germany

University of British Columbia Vancouver Canada

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006413
003      
CZ-PrNML
005      
20200525141723.0
007      
ta
008      
200511s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1164/rccm.201810-1891OC $2 doi
035    __
$a (PubMed)31034279
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Moore, Camille $u 1 National Jewish Health, Denver, Colorado. 2 School of Public Health.
245    10
$a Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis / $c C. Moore, RZ. Blumhagen, IV. Yang, A. Walts, J. Powers, T. Walker, M. Bishop, P. Russell, B. Vestal, J. Cardwell, CR. Markin, SK. Mathai, MI. Schwarz, MP. Steele, J. Lee, KK. Brown, JE. Loyd, JD. Crapo, EK. Silverman, MH. Cho, JA. James, JM. Guthridge, JD. Cogan, JA. Kropski, JJ. Swigris, C. Bair, DS. Kim, W. Ji, H. Kim, JW. Song, LA. Maier, KA. Pacheco, N. Hirani, AS. Poon, F. Li, RG. Jenkins, R. Braybrooke, G. Saini, TM. Maher, PL. Molyneaux, P. Saunders, Y. Zhang, KF. Gibson, DJ. Kass, M. Rojas, J. Sembrat, PJ. Wolters, HR. Collard, JS. Sundy, T. O'Riordan, ME. Strek, I. Noth, SF. Ma, MK. Porteous, ME. Kreider, NB. Patel, Y. Inoue, M. Hirose, T. Arai, S. Akagawa, O. Eickelberg, IE. Fernandez, J. Behr, N. Mogulkoc, TJ. Corte, I. Glaspole, S. Tomassetti, C. Ravaglia, V. Poletti, B. Crestani, R. Borie, C. Kannengiesser, H. Parfrey, C. Fiddler, D. Rassl, M. Molina-Molina, C. Machahua, AM. Worboys, G. Gudmundsson, HJ. Isaksson, DJ. Lederer, AJ. Podolanczuk, SB. Montesi, E. Bendstrup, V. Danchel, M. Selman, A. Pardo, MT. Henry, MP. Keane, P. Doran, M. Vašáková, M. Sterclova, CJ. Ryerson, PG. Wilcox, T. Okamoto, H. Furusawa, Y. Miyazaki, G. Laurent, S. Baltic, C. Prele, Y. Moodley, BS. Shea, K. Ohta, M. Suzukawa, O. Narumoto, SD. Nathan, DC. Venuto, ML. Woldehanna, N. Kokturk, JA. de Andrade, T. Luckhardt, T. Kulkarni, F. Bonella, SC. Donnelly, A. McElroy, ME. Armstong, A. Aranda, RG. Carbone, F. Puppo, KB. Beckman, DA. Nickerson, TE. Fingerlin, DA. Schwartz,
520    9_
$a Rationale: Several common and rare genetic variants have been associated with idiopathic pulmonary fibrosis, a progressive fibrotic condition that is localized to the lung. Objectives: To develop an integrated understanding of the rare and common variants located in multiple loci that have been reported to contribute to the risk of disease. Methods: We performed deep targeted resequencing (3.69 Mb of DNA) in cases (n = 3,624) and control subjects (n = 4,442) across genes and regions previously associated with disease. We tested for associations between disease and 1) individual common variants via logistic regression and 2) groups of rare variants via sequence kernel association tests. Measurements and Main Results: Statistically significant common variant association signals occurred in all 10 of the regions chosen based on genome-wide association studies. The strongest risk variant is the MUC5B promoter variant rs35705950, with an odds ratio of 5.45 (95% confidence interval, 4.91-6.06) for one copy of the risk allele and 18.68 (95% confidence interval, 13.34-26.17) for two copies of the risk allele (P = 9.60 × 10-295). In addition to identifying for the first time that rare variation in FAM13A is associated with disease, we confirmed the role of rare variation in the TERT and RTEL1 gene regions in the risk of IPF, and found that the FAM13A and TERT regions have independent common and rare variant signals. Conclusions: A limited number of common and rare variants contribute to the risk of idiopathic pulmonary fibrosis in each of the resequencing regions, and these genetic variants focus on biological mechanisms of host defense and cell senescence.
650    _2
$a ABC transportéry $x genetika $7 D018528
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a stárnutí buněk $x genetika $7 D016922
650    _2
$a DNA-helikasy $x genetika $7 D004265
650    _2
$a exoribonukleasy $x genetika $7 D005095
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a proteiny aktivující GTPasu $x genetika $7 D020690
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a genetická variace $7 D014644
650    _2
$a celogenomová asociační studie $7 D055106
650    _2
$a vysoce účinné nukleotidové sekvenování $7 D059014
650    _2
$a interakce hostitele a patogenu $x genetika $7 D054884
650    _2
$a lidé $7 D006801
650    _2
$a idiopatická plicní fibróza $x genetika $7 D054990
650    _2
$a logistické modely $7 D016015
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mucin 5B $x genetika $7 D055257
650    _2
$a promotorové oblasti (genetika) $x genetika $7 D011401
650    _2
$a protein A asociovaný s plicním surfaktantem $x genetika $7 D037662
650    _2
$a protein C asociovaný s plicním surfaktantem $x genetika $7 D037721
650    _2
$a RNA $x genetika $7 D012313
650    _2
$a sekvenční analýza DNA $7 D017422
650    _2
$a telomerasa $x genetika $7 D019098
650    _2
$a proteiny vázající telomery $x genetika $7 D034501
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Blumhagen, Rachel Z $u 1 National Jewish Health, Denver, Colorado. 2 School of Public Health.
700    1_
$a Yang, Ivana V $u 3 Department of Medicine, and.
700    1_
$a Walts, Avram $u 3 Department of Medicine, and.
700    1_
$a Powers, Julie $u 3 Department of Medicine, and.
700    1_
$a Walker, Tarik $u 3 Department of Medicine, and.
700    1_
$a Bishop, Makenna $u 3 Department of Medicine, and.
700    1_
$a Russell, Pamela $u 1 National Jewish Health, Denver, Colorado.
700    1_
$a Vestal, Brian $u 1 National Jewish Health, Denver, Colorado.
700    1_
$a Cardwell, Jonathan $u 3 Department of Medicine, and.
700    1_
$a Markin, Cheryl R $u 4 Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.
700    1_
$a Mathai, Susan K $u 3 Department of Medicine, and.
700    1_
$a Schwarz, Marvin I $u 3 Department of Medicine, and.
700    1_
$a Steele, Mark P $u 3 Department of Medicine, and.
700    1_
$a Lee, Joyce $u 3 Department of Medicine, and.
700    1_
$a Brown, Kevin K $u 1 National Jewish Health, Denver, Colorado.
700    1_
$a Loyd, James E $u 4 Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.
700    1_
$a Crapo, James D $u 1 National Jewish Health, Denver, Colorado. 3 Department of Medicine, and.
700    1_
$a Silverman, Edwin K $u 5 Brigham and Women's Hospital, Harvard School of Medicine, Boston, Massachusetts.
700    1_
$a Cho, Michael H $u 5 Brigham and Women's Hospital, Harvard School of Medicine, Boston, Massachusetts.
700    1_
$a James, Judith A $u 6 Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma.
700    1_
$a Guthridge, Joel M $u 6 Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma.
700    1_
$a Cogan, Joy D $u 4 Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.
700    1_
$a Kropski, Jonathan A $u 4 Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.
700    1_
$a Swigris, Jeffrey J $u 1 National Jewish Health, Denver, Colorado.
700    1_
$a Bair, Carol $u 1 National Jewish Health, Denver, Colorado.
700    1_
$a Kim, Dong Soon $u 7 Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
700    1_
$a Ji, Wonjun $u 7 Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
700    1_
$a Kim, Hocheol $u 7 Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
700    1_
$a Song, Jin Woo $u 7 Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
700    1_
$a Maier, Lisa A $u 1 National Jewish Health, Denver, Colorado. 2 School of Public Health. 3 Department of Medicine, and.
700    1_
$a Pacheco, Karin A $u 1 National Jewish Health, Denver, Colorado. 2 School of Public Health.
700    1_
$a Hirani, Nikhil $u 8 MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom. 9 Respiratory Medicine Unit, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
700    1_
$a Poon, Azin S $u 9 Respiratory Medicine Unit, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
700    1_
$a Li, Feng $u 8 MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom.
700    1_
$a Jenkins, R Gisli $u 10 Biomedical Research Centre, University of Nottingham, Nottingham, United Kingdom.
700    1_
$a Braybrooke, Rebecca $u 10 Biomedical Research Centre, University of Nottingham, Nottingham, United Kingdom.
700    1_
$a Saini, Gauri $u 10 Biomedical Research Centre, University of Nottingham, Nottingham, United Kingdom.
700    1_
$a Maher, Toby M $u 11 Royal Brompton Hospital and Imperial College, London, United Kingdom.
700    1_
$a Molyneaux, Philip L $u 11 Royal Brompton Hospital and Imperial College, London, United Kingdom.
700    1_
$a Saunders, Peter $u 11 Royal Brompton Hospital and Imperial College, London, United Kingdom.
700    1_
$a Zhang, Yingze $u 12 Simmons Center for Interstitial Lung Disease, University of Pittsburgh, Pittsburgh, Pennsylvania.
700    1_
$a Gibson, Kevin F $u 12 Simmons Center for Interstitial Lung Disease, University of Pittsburgh, Pittsburgh, Pennsylvania.
700    1_
$a Kass, Daniel J $u 12 Simmons Center for Interstitial Lung Disease, University of Pittsburgh, Pittsburgh, Pennsylvania.
700    1_
$a Rojas, Mauricio $u 12 Simmons Center for Interstitial Lung Disease, University of Pittsburgh, Pittsburgh, Pennsylvania.
700    1_
$a Sembrat, John $u 12 Simmons Center for Interstitial Lung Disease, University of Pittsburgh, Pittsburgh, Pennsylvania.
700    1_
$a Wolters, Paul J $u 13 Department of Medicine, University of California, San Francisco, San Francisco, California.
700    1_
$a Collard, Harold R $u 13 Department of Medicine, University of California, San Francisco, San Francisco, California.
700    1_
$a Sundy, John S $u 14 Gilead Sciences, Foster City, California.
700    1_
$a O'Riordan, Thomas $u 14 Gilead Sciences, Foster City, California.
700    1_
$a Strek, Mary E $u 15 Department of Medicine, University of Chicago, Chicago, Illinois.
700    1_
$a Noth, Imre $u 16 Department of Medicine, University of Virginia, Charlottesville, Virginia.
700    1_
$a Ma, Shwu-Fan $u 16 Department of Medicine, University of Virginia, Charlottesville, Virginia.
700    1_
$a Porteous, Mary K $u 17 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
700    1_
$a Kreider, Maryl E $u 17 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
700    1_
$a Patel, Namrata B $u 17 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
700    1_
$a Inoue, Yoshikazu $u 18 National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.
700    1_
$a Hirose, Masaki $u 18 National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.
700    1_
$a Arai, Toru $u 18 National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.
700    1_
$a Akagawa, Shinobu $u 19 National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
700    1_
$a Eickelberg, Oliver $u 3 Department of Medicine, and. 20 Helmholtz Zentrum München, Neuherberg, Germany.
700    1_
$a Fernandez, Isis Enlil $u 20 Helmholtz Zentrum München, Neuherberg, Germany.
700    1_
$a Behr, Jürgen $u 21 University Hospital Munich, Munich, Germany.
700    1_
$a Mogulkoc, Nesrin $u 22 Department of Pulmonology, Ege University Hospital, Bornova, Izmir, Turkey.
700    1_
$a Corte, Tamera J $u 23 Royal Prince Alfred Hospital and University of Sydney, Sydney, Australia.
700    1_
$a Glaspole, Ian $u 24 Alfred Hospital and Monash University, Melbourne, Australia.
700    1_
$a Tomassetti, Sara $u 25 Pulmonary Medicine, GB Morgagni Hospital, Forlì, Italy.
700    1_
$a Ravaglia, Claudia $u 26 Department of Diseases of the Thorax, Ospedale GB Morgagni, Forlì, Italy.
700    1_
$a Poletti, Venerino $u 26 Department of Diseases of the Thorax, Ospedale GB Morgagni, Forlì, Italy.
700    1_
$a Crestani, Bruno $u 27 Université Paris Diderot and Hôpital Bichat, Paris, France.
700    1_
$a Borie, Raphael $u 27 Université Paris Diderot and Hôpital Bichat, Paris, France.
700    1_
$a Kannengiesser, Caroline $u 27 Université Paris Diderot and Hôpital Bichat, Paris, France.
700    1_
$a Parfrey, Helen $u 28 Royal Papworth Hospital and Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
700    1_
$a Fiddler, Christine $u 28 Royal Papworth Hospital and Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
700    1_
$a Rassl, Doris $u 28 Royal Papworth Hospital and Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
700    1_
$a Molina-Molina, Maria $u 29 Respiratory Department, University Hospital of Bellvitge, University of Barcelona, Barcelona, Spain.
700    1_
$a Machahua, Carlos $u 29 Respiratory Department, University Hospital of Bellvitge, University of Barcelona, Barcelona, Spain.
700    1_
$a Worboys, Ana Montes $u 29 Respiratory Department, University Hospital of Bellvitge, University of Barcelona, Barcelona, Spain.
700    1_
$a Gudmundsson, Gunnar $u 30 National University Hospital of Iceland, University of Iceland, Reykjavik, Iceland.
700    1_
$a Isaksson, Helgi J $u 30 National University Hospital of Iceland, University of Iceland, Reykjavik, Iceland.
700    1_
$a Lederer, David J $u 31 Department of Medicine, Columbia University Irving Medical Center, New York, New York.
700    1_
$a Podolanczuk, Anna J $u 31 Department of Medicine, Columbia University Irving Medical Center, New York, New York.
700    1_
$a Montesi, Sydney B $u 32 Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, Massachusetts.
700    1_
$a Bendstrup, Elisabeth $u 33 Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.
700    1_
$a Danchel, Vivi $u 33 Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.
700    1_
$a Selman, Moises $u 34 Instituto Nacional de Enfermedades Respiratorias "Ismael Cosio Villegas," México City, México.
700    1_
$a Pardo, Annie $u 35 Universidad Nacional Autónoma de México, México City, México.
700    1_
$a Henry, Michael T $u 36 Cork University Hospital and University College Cork, Cork, Ireland.
700    1_
$a Keane, Michael P $u 37 St. Vincent's University Hospital, Dublin, Ireland. 38 School of Medicine, University College Dublin, Dublin, Ireland.
700    1_
$a Doran, Peter $u 37 St. Vincent's University Hospital, Dublin, Ireland. 38 School of Medicine, University College Dublin, Dublin, Ireland.
700    1_
$a Vašáková, Martina $u 39 Department of Respiratory Medicine, First Faculty of Medicine Charles University and Thomayer Hospital, Prague, Czech Republic.
700    1_
$a Sterclova, Martina $u 39 Department of Respiratory Medicine, First Faculty of Medicine Charles University and Thomayer Hospital, Prague, Czech Republic.
700    1_
$a Ryerson, Christopher J $u 40 University of British Columbia, Vancouver, Canada.
700    1_
$a Wilcox, Pearce G $u 40 University of British Columbia, Vancouver, Canada.
700    1_
$a Okamoto, Tsukasa $u 3 Department of Medicine, and. 41 Tokyo Medical and Dental University, Tokyo, Japan.
700    1_
$a Furusawa, Haruhiko $u 3 Department of Medicine, and. 41 Tokyo Medical and Dental University, Tokyo, Japan.
700    1_
$a Miyazaki, Yasunari $u 41 Tokyo Medical and Dental University, Tokyo, Japan.
700    1_
$a Laurent, Geoffrey $u 42 Institute for Respiratory Health and. 43 Centre for Cell Therapy and Regenerative Medicine, School of Biomedical Sciences, The University of Western Australia, Perth, Australia.
700    1_
$a Baltic, Svetlana $u 42 Institute for Respiratory Health and.
700    1_
$a Prele, Cecilia $u 42 Institute for Respiratory Health and. 43 Centre for Cell Therapy and Regenerative Medicine, School of Biomedical Sciences, The University of Western Australia, Perth, Australia.
700    1_
$a Moodley, Yuben $u 42 Institute for Respiratory Health and.
700    1_
$a Shea, Barry S $u 44 Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island.
700    1_
$a Ohta, Ken $u 19 National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
700    1_
$a Suzukawa, Maho $u 19 National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
700    1_
$a Narumoto, Osamu $u 19 National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
700    1_
$a Nathan, Steven D $u 45 Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, Virginia.
700    1_
$a Venuto, Drew C $u 45 Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, Virginia.
700    1_
$a Woldehanna, Merte L $u 45 Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, Falls Church, Virginia.
700    1_
$a Kokturk, Nurdan $u 46 Department of Pulmonary Medicine, Gazi University School of Medicine, Ankara, Turkey.
700    1_
$a de Andrade, Joao A $u 47 Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
700    1_
$a Luckhardt, Tracy $u 47 Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
700    1_
$a Kulkarni, Tejaswini $u 47 Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
700    1_
$a Bonella, Francesco $u 48 Ruhrlandklinik, University Hospital, University of Duisburg-Essen, Essen, Germany.
700    1_
$a Donnelly, Seamus C $u 49 Department of Medicine, Tallaght University Hospital, Trinity College Dublin, Dublin, Ireland.
700    1_
$a McElroy, Aoife $u 49 Department of Medicine, Tallaght University Hospital, Trinity College Dublin, Dublin, Ireland.
700    1_
$a Armstong, Michelle E $u 49 Department of Medicine, Tallaght University Hospital, Trinity College Dublin, Dublin, Ireland.
700    1_
$a Aranda, Alvaro $u 50 CardioPulmonary Reserach Center, Alliance Pulmonary Group, Guaynabo, Puerto Rico.
700    1_
$a Carbone, Roberto G $u 51 Department of Internal Medicine, University of Genoa, Genoa, Italy.
700    1_
$a Puppo, Francesco $u 51 Department of Internal Medicine, University of Genoa, Genoa, Italy.
700    1_
$a Beckman, Kenneth B $u 52 Biomedical Genomics Center, University of Minnesota; Minneapolis, Minnesota; and.
700    1_
$a Nickerson, Deborah A $u 53 Northwest Genomics Center, University of Washington, Seattle, Washington.
700    1_
$a Fingerlin, Tasha E $u 1 National Jewish Health, Denver, Colorado. 2 School of Public Health. 3 Department of Medicine, and.
700    1_
$a Schwartz, David A $u 1 National Jewish Health, Denver, Colorado. 3 Department of Medicine, and. 54 Department of Immunology, University of Colorado Denver, Denver, Colorado.
773    0_
$w MED00000297 $t American journal of respiratory and critical care medicine $x 1535-4970 $g Roč. 200, č. 2 (2019), s. 199-208
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31034279 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200525141722 $b ABA008
999    __
$a ok $b bmc $g 1525271 $s 1096469
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 200 $c 2 $d 199-208 $e 20190715 $i 1535-4970 $m American journal of respiratory and critical care medicine $n Am J Respir Crit Care Med $x MED00000297
GRA    __
$a P01 HL092870 $p NHLBI NIH HHS $2 United States
GRA    __
$a U54 GM104938 $p NIGMS NIH HHS $2 United States
GRA    __
$a P30 AR053483 $p NIAMS NIH HHS $2 United States
GRA    __
$a MR/N005953/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a P30 AR073750 $p NIAMS NIH HHS $2 United States
GRA    __
$a R01 HL097163 $p NHLBI NIH HHS $2 United States
GRA    __
$a UL1 RR024975 $p NCRR NIH HHS $2 United States
GRA    __
$a R33 HL120770 $p NHLBI NIH HHS $2 United States
GRA    __
$a U19 AI082714 $p NIAID NIH HHS $2 United States
GRA    __
$a K08 HL130595 $p NHLBI NIH HHS $2 United States
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...